ExonHit Therapeutics SA Product Pipeline Analysis

SUMMARY

ExonHit Therapeutics SA Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a ExonHit Therapeutics SA's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List Of Tables 6
1.2 List of Figures 7
2 Company Overview 8
2.1 Key Information 8
2.2 Industry Outlook -- In Vitro Diagnostics 8
3 Major Products and Services 9
3.1 Overview 9
4 Competitors 10
5 Key Employees 11
6 Locations And Subsidiaries 12
6.1 Head Office 12
6.2 Other Locations & Subsidiaries 12
7 Recent Developments 13
7.1 Corporate Communications 13
7.1.1 Apr 30, 2008: ExonHit Announces Board Changes 13
7.1.2 Mar 31, 2008: ExonHit Appoints New Management Board 13
7.2 Product News 14
7.2.1 Jan 09, 2008: EXONHIT AND BIOMERIEUX AMEND THEIR STRATEGIC PARTNERSHIP 14
7.2.2 Dec 20, 2007: Exonhit Gets Regulatory Approval To Initiate A Phase 2 Clinical Trial For EHT 0202 In Alzheimer's Disease 14
7.2.3 Nov 08, 2007: Exonhit Completes A Prototype To Detect Alzheimer's Disease From Blood 15
7.2.4 Jun 07, 2007: In 2009 Exonhit Aims To Ask For Market Clearance In Europe For A Blood Diagnostic Test For Alzheimer's Disease 15
7.3 Product Approvals 15
7.3.1 Dec 20, 2007: Exonhit Gets Regulatory Approval To Initiate A Phase 2 Clinical Trial For EHT 0202 In Alzheimer's Disease 15
8 ExonHit Therapeutics SA Pipeline Products 16
8.1 ExonHit Therapeutics SA Product Pipeline Analysis 16
8.1.1 ExonHit Therapeutics SA Pipeline Products By Equipment Type 16
8.1.2 ExonHit Therapeutics SA Pipeline Products By Development Stage 18
8.1.3 ExonHit Therapeutics SA Pipeline Products By Therapy Area 18
8.1.4 ExonHit Therapeutics SA Pipeline Products By News Summary 19
8.2 EHT Dx 21 19
8.2.1 Product Description 20
8.2.2 Product Status 20
8.3 EHT Dx 31 20
8.3.1 Product Description 20
8.3.2 Product Status 21
8.4 EHT Dx 11 21
8.4.1 Product Description 21
8.4.2 Product Status 21
8.5 EHT Dx 12 22
8.5.1 Product Description 22
8.5.2 Product Status 22
8.6 EHT Dx13 22
8.6.1 Product Description 22
8.6.2 Product Status 23
8.7 Diagnostic Test for Alzheimer's Disease 23
8.7.1 Product Description 23
8.7.2 Product Status 23
8.7.3 Product Milestone 23
8.7.4 Product Patent Details 24
9 Appendix 25
9.1 Methodology 25
9.1.1 Coverage 25
9.1.2 Secondary Research 26
9.1.3 Primary Research 26
9.1.4 Expert Panel Validation 27
9.2 Contact Us 27
9.3 About Global Markets Direct 27
9.4 Disclaimer 27

1.1 List of Tables
Table 1: ExonHit Therapeutics SA,Key Facts 8
Table 2: ExonHit Therapeutics SA, Key Employees, 11
Table 3: ExonHit Therapeutics SA, Subsidiaries 12
Table 4: ExonHit Therapeutics SA Pipeline Products by Equipment Type 17
Table 5: ExonHit Therapeutics SA Pipeline Products By Development Stage 18
Table 6: ExonHit Therapeutics SA Pipeline Products By Therapy Area 18
Table 7: ExonHit Therapeutics SA Pipeline Products By News Summaries 19

1.2 List of Figures
Figure 1: ExonHit Therapeutics SA Pipeline Products By Equipment Type 16
Figure 2: ExonHit Therapeutics SA Pipeline Products By Equipment Type 17
Figure 3: ExonHit Therapeutics SA Pipeline Products By Development Stage 18
Figure 4: ExonHit Therapeutics SA Pipeline Products By News Summary 19
Figure 5: Global Markets Direct Methodology 25